ESC 365 - Consistent platelet inhibition with ticagrelor 60 mg twice-daily following myocardial infarction regardless of diabetic status

ESC Premium Access

Consistent platelet inhibition with ticagrelor 60 mg twice-daily following myocardial infarction regardless of diabetic status

Session: Poster session 6 - Antiplatelet therapy

Topic: Thrombosis and platelets

Speaker: Doctor M. Thomas (Birmingham, GB)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Doctor Mark Robert Thomas

University of Birmingham, Birmingham (United Kingdom of Great Britain & Northern Ireland)

0 follower

22 more presentations in this session

Comparison of the new oral P2Y12 inhibitor (Prasugrel/Ticagrelor) to Clopidogrel in type 2 diabetes mellitus patients with AMI

Speaker: Doctor M. Kim (Daejeon, KR)

Impact of antiplatelet drugs on cholesterol level of platelet lipid rafts

Speaker: Mrs V. Rabani (Besancon, FR)

Optical coherence tomography assessment of in-stent thrombus immediately after percutaneous coronary intervention in patients pretreatment with Prasugrel compared to Clopidogre

Speaker: Doctor Y. Katayama (Wakayama, JP)

Circadian variation of platelets inhibition with ticagrelor

Speaker: Doctor S. Fournier (Lausanne, CH)

Platelet reactivity is gender and age related

Speaker: Mr G. Vos (Nieuwegein, NL)

Access the full session

Poster session 6 - Antiplatelet therapy

Speakers: Doctor M. Thomas, Doctor M. Kim, Mrs V. Rabani, Doctor Y. Katayama, Doctor S. Fournier...

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources